Goosehead director granted 13,979 stock options
Goosehead Insurance, Inc. director Wade William Francis Jr received a grant of 13,979 Director Stock Options to acquire Class A Common Stock at an exercise price of $42.46 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Goosehead Insurance, Inc. director Wade William Francis Jr received a grant of 13,979 Director Stock Options to acquire Class A Common Stock at an exercise price of $42.46 per share. The options were granted at no cost and will vest in 12 equal quarterly installments over three years, subject to continued service. All 13,979 options will fully vest upon a change in control under the company’s Amended and Restated Omnibus Incentive Plan, and the filing shows 13,979 derivative securities held directly after the grant.
Insider Trade Summary
Grant/Award: 13,979 shares
Grant/Award
1 txn
Insider
Wade William Francis Jr
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Director Stock Options (right to buy) | 13,979 | $0.00 | $0.00 |
Holdings After Transaction:
Director Stock Options (right to buy) — 13,979 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option shall vest and become exercisable, subject to continued service, in 12 equal quarterly installments over the three (3) year period following the grant date; provided that all shares subject to the option will vest and become exercisable upon a "change in control" (as defined in the Issuer's Amended and Restated Omnibus Incentive Plan).
Key Figures
Option grant size: 13,979 options
Exercise price: $42.46 per share
Vesting schedule: 12 equal quarterly installments
+3 more
6 metrics
Option grant size
13,979 options
Director Stock Options granted on May 5, 2026
Exercise price
$42.46 per share
Exercise price for Class A Common Stock under the options
Vesting schedule
12 equal quarterly installments
Over three years following the grant date, subject to continued service
Change in control vesting
100% of 13,979 options
All options vest upon a change in control under the incentive plan
Post-transaction holdings
13,979 derivative securities
Total Director Stock Options held directly after the grant
Option expiration date
May 5, 2036
Expiration date of the Director Stock Options if unexercised
Key Terms
Director Stock Options, Class A Common Stock, change in control, Amended and Restated Omnibus Incentive Plan
4 terms
Director Stock Options financial
"Director Stock Options (right to buy)"
Stock options granted to a company’s board members that give those directors the right to buy company shares at a preset price after certain conditions are met. They matter to investors because they align directors’ incentives with shareholders—encouraging decisions that could raise the share price—but also create potential share dilution and future selling pressure once the options are exercised, similar to giving a delayed bonus tied to performance.
Class A Common Stock financial
"underlying_security_title": "Class A Common Stock""
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
change in control financial
"will vest and become exercisable upon a "change in control""
A "change in control" occurs when the ownership or management of a company shifts significantly, such as through a merger, acquisition, or sale of a large part of its assets. This change can impact how the company is run and may influence its future direction. For investors, it matters because it can affect the company's stability, strategy, and value, often signaling potential changes in investment risk or opportunity.
Amended and Restated Omnibus Incentive Plan financial
"as defined in the Issuer's Amended and Restated Omnibus Incentive Plan"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Goosehead Insurance (GSHD) director Wade William Francis Jr receive in this Form 4?
He received a grant of 13,979 Director Stock Options at an exercise price of $42.46 per share. These options allow him to buy Class A Common Stock in the future, subject to the vesting schedule and other plan terms described.
What is the exercise price of the Goosehead Insurance (GSHD) options granted?
The options have an exercise price of $42.46 per share, meaning that is the price he must pay to buy each share when exercising. This price is fixed under the terms of the option grant reported.
How do the Goosehead Insurance (GSHD) director options vest over time?
The 13,979 options vest and become exercisable in 12 equal quarterly installments over three years, subject to continued service. This means one-twelfth of the grant becomes exercisable every quarter until fully vested.
What happens to the Goosehead Insurance (GSHD) options if there is a change in control?
All 13,979 options will fully vest and become exercisable upon a change in control, as defined in the Amended and Restated Omnibus Incentive Plan. This accelerates vesting compared with the normal quarterly three-year schedule.
How many Goosehead Insurance (GSHD) options does the director hold after this transaction?
After this grant, the filing reports total derivative securities of 13,979 options held directly. This reflects the newly awarded Director Stock Options as of the transaction date disclosed.
When do the Goosehead Insurance (GSHD) director options expire?
The options are scheduled to expire on May 5, 2036, if not exercised earlier. After that expiration date, any unexercised options would no longer be exercisable under the terms reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.
